The evaluation of cognitive functions with P300 test for chronic obstructive pulmonary disease patients in attack and stable period

Clinical Neurology and Neurosurgery

Volumn 109, Issue 7, 2007, Pages 553-560

  Kirkil, Gamze ^a   Tug, Tuncer ^b   Ozel, Eda ^a   Bulut, Serpil ^a   Tekatas, Aslan ^a   Muz, Mehmet Hamdi ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

Arterial blood gas analysis; Chronic obstructive pulmonary disease; Cognitive function; P300 amplitude; P300 latency; Pulmonary function test

Indexed keywords

AGED; ARTERIAL GAS; ARTERIAL OXYGEN SATURATION; ARTERIAL OXYGEN TENSION; ARTICLE; BRAIN PERFUSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EVOKED RESPONSE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LATENT PERIOD; LUNG FUNCTION TEST; MALE; MEASUREMENT; STATISTICAL SIGNIFICANCE;

AGED; ANOXIA; ATTENTION; CEREBRAL CORTEX; COGNITION DISORDERS; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; OXYGEN; PITCH DISCRIMINATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REACTION TIME; REFERENCE VALUES; VITAL CAPACITY;

EID: 34347331362     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2007.03.013     Document Type: Article

References (36)

1. American Thoracic Society. Standards for the diagnosis care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152 (1995) 77-121
2. Grant I., Heaton R.K., McSweeney A.J., Adams K.M., and Timms R.M. Brain dysfunction in COPD. Chest 77 (1980) 308-309
3. Strasser A., Stanimirovic D., Kawai N., McCarron R.M., and Spatz M. Hypoxia modulates free radical formation in brain microvascular endothelium. Acta Neurochir Suppl 70 (1997) 8-11
4. Tug T., Karatas F., and Terzi S.M. Antioxidant vitamins (A, C and E) and malondialdehyde levels in acute exacerbation and stable periods of patients with chronic obstructive pulmonary disease. Clin Invest Med 27 3 (2004) 123-128
5. Raffaele A.I., Andrea C., Claudio P., Luigi T., Domenico A., Aldo S., et al. Drawing impairment predicts mortality in severe COPD. Chest 130 6 (2006) 1687-1694
6. Etnier J., Johnston R., Dagenbach D., Pollard R.J., Rejeski W.J., and Berry M. The relationships among pulmonary function, aerobic fitness, and cognitive functioning in older COPD patients. Chest 116 (1999) 953-960
7. Ortapamuk H., and Naldoken S. Brain perfusion abnormalities in chronic obstructive pulmonary disease: comparison with cognitive impairment. Ann Nucl Med 20 2 (2006) 99-106
8. Polich J., and Herbst K.L. P300 as a clinical assay: rationale, evaluation, and findings. Int J Psychophysiol 38 (2000) 3-19
9. Polich J. P300 clinical utility and control of variability. J Clin Neurophysiol 15 (1998) 14-33
10. Emmerson R.Y., Dustman R.E., Shearer D.E., and Turner C.W. P3 latency and symbol digit performance correlations in aging. Exp Aging Res 15 3-4 (1989) 151-159
11. Mavioǧlu H., Çelik P., Yorganci{dotless}oǧlu A., Yi{dotless}lmaz H., and Keskin T. The evaluation of cognitive functions and P300 in chronic obstructive pulmonary disease. J Neurol Sci (Turkish) 17 (2000) 32-37
12. Reeves R.R., Struve F.A., Patrick G., Payne D.K., and Thirstrup L.L. Auditory and visual P300 cognitive evoked responses in patients with COPD: relationship to degree of pulmonary impairment. Clin Electroencephalogr 30 (1999) 122-125
13. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease updated 2005. Executive summary. Based on an April 1998 NHLB/Workshop.
14. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. (revised) (1988), American Psychiatric Association, Washington, DC
15. Incalzi R.A., Gemma A., Marra C., Muzzolon R., Capparella O., and Carbonin P. Chronic obstructive pulmonary disease. An original model of cognitive decline. Am Rev Respir Dis 148 (1993) 418-424
16. Krop H.D., Block A.J., and Cohen E. Neuropsychologic effects of continuous oxygen therapy in chronic obstructive pulmonary disease. Chest 64 (1973) 317-322
17. Grant I., Heaton R.K., McSweeny A.J., Adams K.M., and Timms R.M. Neurophsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med 142 (1982) 1470-1476
18. Prigatano G.P., Parsons O.A., Wright E., Levin D.C., and Hawryluk G. Neuropsychologic test performance in mildly hypoxemic patients with chronic obstructive pulmonary disease. J Consult Clin Psychol 51 (1983) 108-116
19. Dulfano M.J., and Ishikawa S. Hypercapnia: mental changes and extrapulmonary complications. An expanded concept of the "CO-2 intoxication" syndrome. Ann Intern Med 63 (1965) 829-841
20. Gibson T.M. Effects of hypocapnia on psychomotor and intellectual performance. Aviat Space Environ Med 49 (1978) 943-946
21. Incalzi R.A., Marra C., Giordano A., Calcagni M.L., Cappa A., Basso S., et al. Cognitive impairment in chronic obstructive pulmonary disease-a neuropsychological and spect study. J Neurol 250 3 (2003) 325-332
22. Fix A.J., Golden C.J., Daughton D., Kass I., and Bell C.W. Neuropsychological deficits among patients with chronic obstructive pulmonary disease. Int J Neurosci 16 (1982) 99-105
23. Fioravanti M., Nacca D., Amati S., Buckley A.E., and Bisetti A. Chronic obstructive pulmonary disease and associated patterns of memory decline. Dementia 6 (1995) 39-48
24. Isoaho R., Puolijoki H., Huhti E., Laippala P., and Kivela S.L. Chronic obstructive pulmonary disease and cognitive impairment in the elderly. Int Psychogeriatr 8 (1996) 113-125
25. Orth M., Kotterba S., Duchna K., Widdig W., Rasche K., Schultze-Werninghaus G., et al. Cognitive deficits in patients with chronic obstructive pulmonary disease (COPD). Pneumologie 60 10 (2006) 593-599
26. Grant I., Prigatano G.P., Heaton R.K., McSweeny A.J., Wright E.C., and Adams K.M. Progressive neurophsychologic impairment and hypoxemia. Relationship in chronic obstructive pulmonary disease. Arch Gen Psychiatry 44 (1987) 999-1006
27. Schaie K.W. The course of adult intellectual development. Am Psychol 49 (1994) 304-313
28. Incalzi R.A., Chiappini F., Fuso L., Torrice M.P., Gemma A., and Pistelli R. Predicting cognitive decline in patients with hypoxaemic COPD. Respir Med 92 3 (1998) 527-533
29. Liesker J.J., Postma D.S., Beukema R.J., ten Hacken N.H., van der Molen T., Riemersma R.A., et al. Cognitive performance in patients with COPD. Resp Med 98 (2004) 351-356
30. Atiş S., Ozge A., and Sevim S. The brainstem auditory evoked potential abnormalities in severe chronic obstructive pulmonary disease. Respirology 6 (2001) 225-229
31. Stuss D.T., Peterkin I., Guzman D.A., Guzman C., and Troyer A.K. Chronic obstructive pulmonary disease: effects of hypoxia on neurological and neuropsychological measures. J Clin Exp Neuropsychol 19 4 (1997) 515-524
32. Heaton R.K., Grant I., McSweeny A.J., Adams K.M., and Petty T.L. Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med 143 (1983) 1941-1947
33. Cossa F.M., Della Sala S., and Spinnler H. Alzheimer's and Parkinson's patients selective attention. Their sensitivity to memory and data-driven control. Neuropsychologia 27 (1989) 887-892
34. de la Torre J.C. Critical threshold cerebral hypoperfusion causes Alzheimer's disease?. Acta Neuropathol (Berl) 98 (1999) 1-8
35. Ambrosino N., Bruletti G., Scala V., Porta R., and Vitacca M. Cognitive and perceived health status in patient with chronic obstructive pulmonary disease surviving acute on chronic respiratory failure: a controlled study. Intensive Care Med 28 (2002) 170-177
36. Webster K.E., and Colrain I.M. P3-specific amplitude reductions to respiratory and auditory stimuli in subjects with asthma. Am J Respir Crit Care Med 166 1 (2002) 47-52